Close
ACHEMA MIDDLE EAST 2026

LAI Antipsychotic – Given The Green Light Across The EU

It is indeed worth noting the fact that the first once-every-two-months long-acting injectable- LAI antipsychotic, given a nod by the European Commission- EC is...

New Advancements – A Game-Changer In Biological Drug Delivery

It is worth noting that the pharmaceutical sector happens to be steadily shifting toward what are known as biologics, or biological drugs. The fact...

Innovation To Propel The Advanced Drug Delivery Sector

One of the reports by Towards Healthcare has gone on to forecast that the advanced drug delivery market is going to value $375.86 billion...

Use of Automation Fuelled By Growing Pharmaceutical Output

PMMI, which is the Association for Packaging and Processing Technologies, goes on to note that the forecasted expansion of the pharma machinery market happens...

Drug Manufacturing Is Well-Positioned For A Potential Growth

The bio and pharma manufacturing industry happens to be an ever-growing as well as evolving landscape, wherein the emerging modalities and shifts in the...

The Manufacturing Outsourcing Trend Prompted By Biopharma

Interestingly, one of the research projects by Root Analysis goes on to predict that pharmaceutical contract manufacturing market is all set to be valued...

New Era In Drug Packaging: Redefining Safety, Sustainability

In an era that happens to be marked by quick advancements in biotechnology as well as pharmaceuticals, the evolution when it comes to drug...

Subscribe Our Newsletter

White Papers

The Future of Digital Health

The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

Five Best Practices to Deliver Exceptional Multichannel Experiences

A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

The Impact and Use of Social Media in Pharmacovigilance

Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...